TY  - GEN
AU  - Wiley,Henry E
AU  - Thompson,Darby J S
AU  - Bailey,Clare
AU  - Chew,Emily Y
AU  - Cukras,Catherine A
AU  - Jaffe,Glenn J
AU  - Lee,Richard W J
AU  - Loken,Erin K
AU  - Meyerle,Catherine B
AU  - Wong,Wai
AU  - Ferris,Frederick L
TI  - A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema
SN  - 1549-4713
PY  - 2016///0811
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Bevacizumab
KW  - Cross-Over Studies
KW  - Diabetes Mellitus, Type 1
KW  - complications
KW  - Diabetes Mellitus, Type 2
KW  - Diabetic Retinopathy
KW  - drug therapy
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - Male
KW  - Middle Aged
KW  - Ranibizumab
KW  - Research Design
KW  - Retina
KW  - pathology
KW  - Tomography, Optical Coherence
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - drug effects
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ophtha.2015.11.021
ER  -